Building On Successes During Turbulent Times, SR One Closes $600m Fund II

$1.1bn Raised Since Spinning Out Of GSK

 
• By Mandy Jackson
  
Wooden blocks with words 'Venture Capital'
SR One invests in new companies, early- and late-stage biotechs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business